Georgetown University Medical Center - Department of Rheumatology is a clinical research site located in Washington D.C., District of Columbia, United States 20007.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Georgetown University Medical Center - Department of Rheumatology has participated in 6 clinical trials with 1 currently active.
Therapeutic areas: Raynaud's Phenomenon Secondary to Systemic Sclerosis, Raynaud Phenomenon Secondary to Systemic Sclerosis, Pulmonary Hypertension.
Sponsors: Civi Biopharma, Inc., Biogen, Scleroderma Research Foundation, Inc..
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Georgetown University Medical Center - Department of Rheumatology has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Georgetown University Medical Center - Department of Rheumatology has 6 clinical trials on record, with 1 currently active. Their work covers Raynaud's Phenomenon Secondary to Systemic Sclerosis, Raynaud Phenomenon Secondary to Systemic Sclerosis, Pulmonary Hypertension.
Yes — Georgetown University Medical Center - Department of Rheumatology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.